通过蛋白质阵列分析发现与深静脉血栓形成相关的关键细胞因子
Qitao Wang1, Junyu Chi1, Wenjie Zeng1
1Vascular Gland Surgery, The First Affiliated Hospital of Hebei North University, Hebei province, Zhangjiakou, 075000, China.
BMC cardiovascular disorders
|July 18, 2024
概括
这项研究确定了12种新的血清生物标志物,包括FGF-6和Galectin-3,用于改善深静脉血栓症 (DVT) 检测. 这些发现为早期诊断和更好地管理DVT提供了潜力.
科学领域:
- 生物化学和分子生物学
- 医学诊断 医学诊断 医学诊断
- 生物标志物发现发现
背景情况:
- 静脉血栓栓塞 (VTE) 预测和病因学研究需要扩大生物标志物识别.
- 早期深静脉血栓 (DVT) 检测和减少并发症需要新的生物标志物和向疗法.
研究的目的:
- 确定有希望的基于血清的生物标志物,以提高早期DVT的检测准确度.
- 探索潜在的针对性治疗DVT,并减少相关的并发症.
主要方法:
- 使用的量子体人类细胞因子抗体阵列440 (QAH-CAA-440) 用于在DVT/非下肢DVT (NDVT) 中进行新型血清生物标志物查.
- 应用生物信息学用于差异蛋白质分析,随后使用定制阵列和接收器操作特征 (ROC) 分析进行验证.
- 采用机器学习来开发一个生物标志物模型来评估已识别的目标,选择十二个用于验证.
主要成果:
- 细胞因子分析确定了12个具有高诊断准确性的关键生物标志物 (AUC从0.773到0.956不等).
- 关键的验证生物标志物包括FGF-6 (AUC=0.956),加勒-3 (AUC=0.942),EDA-A2 (AUC=0.933),以及CHI3L1 (AUC=0.911).这些生物标志物中,FGF-6是最重要的.
- 这些细胞因子在区分DVT与NDVT方面表现出显著的潜力.
结论:
- EDA-A2,FGF-6,Dkk-4,IL-1 F9,Galectin-3,Layilin,Big-h3,CHI3L1,ULBP-2,Gas-1,IGFBP-5和FGF-9被认为是有前途的生物标志物.这些生物标志物中,FGF-5和FGF-9是最重要的生物标志物.
- 这些生物标志物代表了DVT诊断和治疗干预的潜在目标.
- 这项研究强调了细胞因子分析在发现DVT的新生物标志物的有用性.
相关概念视频
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
668
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
668
Clot Retraction and Fibrinolysis
5.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.4K


